Aberrant lipid metabolism identified in early-stage lung cancer
(HealthDay)—A plasma assay that detects dysregulated lipids has potential as a screening method for early-stage lung cancer, according to a study published in the Feb. 2 issue of Science Translational Medicine.
Feb 3, 2022
0
2